Metaproterenol Sulfate Suppliers & Bulk Manufacturers

Available Forms: Tablet / Syrup / Inhalation Solution

Available Strengths: 10 mg, 15 mg,5 mg/5 m

Reference Brands: Generic formulations marketed under different names

Category: Respiratory Disorder

Metaproterenol Sulfate is available in Tablet / Syrup / Inhalation Solution and strengths such as 10 mg, 15 mg,5 mg/5 m. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Metaproterenol Sulfate is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Metaproterenol Sulfate can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Orciprenaline, also known as metaproterenol, is a bronchodilator used in the management of asthma and other reversible obstructive airway diseases. It is a moderately selective β2-adrenergic receptor agonist that primarily targets smooth muscles in the lungs, while having minimal effects on α-adrenergic receptors. By stimulating β2 receptors, orciprenaline activates intracellular adenylyl cyclase, which increases cyclic AMP (cAMP) levels within the cells. Elevated cAMP promotes relaxation of bronchial smooth muscle, resulting in bronchodilation and improved airflow.

In addition, orciprenaline inhibits the release of mediators of immediate hypersensitivity from mast cells and other immune cells, helping to reduce inflammation and bronchoconstriction associated with asthma attacks. It is available in multiple formulations, including oral tablets, syrup, and inhalation solutions, providing flexibility for both acute and chronic management of respiratory conditions.

Orciprenaline (metaproterenol) provides rapid relief from symptoms such as wheezing, shortness of breath, and coughing, making it an effective therapy for bronchospasm in asthma, chronic bronchitis, and other reversible obstructive pulmonary disorders. Its targeted β2 agonist activity ensures bronchodilation with minimal cardiovascular side effects compared to non-selective adrenergic agents.